Document Details

MGEN $7.94   $ (0.39) (5.17)%
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 3/31/2017
Filing Date 3/31/2017

Abstract: 8-K filed by Miragen Therapeutics covering Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; and Financial Statements and Exhibits.
Download

File Section(s)

  1. 8-K
  2. EX-10.1
  3. EX-99.1
  4. EX-99.2

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.